US Sciele Pharma to buy Victory Pharma for USD150m
SCRX | Quote | Chart | News | PowerRating -- US company Sciele Pharma said on 18 May 2009 it has agreed to buy local
privately-held pharmaceutical firm Victory Pharma for USD150m (EUR111m).
The deal is scheduled for closing in the second quarter of the year.
The transaction is in line with Sciele's strategic plan to further
diversify its product portfolio.
Sciele Pharma, part of Japanese pharmaceutical group Shionogi & Co Ltd,
specialises in selling, marketing and development of branded
prescription products for cardiovascular complaints, diabetes, women's
health and pediatrics.
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing: Cash
Target: Victory Pharma Inc
Buyer: Sciele Pharma Inc
Status: Agreed
Comments on this story may be sent to admin@m2.com
For full details on (SCRX) SCRX. (SCRX) has Short Term PowerRatings at TradingMarkets. Details on (SCRX) Short Term PowerRatings is available at This Link.
- Sciele Pharma, Inc., a Shionogi Group Company, Announces Name Change - 01/11/10
- Sciele Introduces Adrenaclick(TM) (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis - 01/07/10
- LifeCycle Pharma secures Notice of Allowance for US patent for Fenoglide - 12/17/09
- LifeCycle Pharma Receives Notice of Allowance for U.S. Patent on Fenoglide(R) - 12/17/09
- Ã" - 12/09/09
- More News >>


